WASHINGTON (Legal Newsline) — The U.S. Department of Justice announced Sept. 13 that MediSys Health Network Inc., which owns and operates Jamaica Hospital Medical Center and Flushing Hospital and Medical Center, two hospitals in Queens, New York, will pay $4 million after allegations of violating the False Claims Act via improper financial relationships with physicians.
WASHINGTON (Legal Newsline) — The U.S. Department of Justice announced Sept. 5 that Novo Nordisk Inc., a pharmaceutical manufacturing company, will pay $58.65 million after allegations of failing to comply with the FDA-mandated risk evaluation and mitigation strategy (REMS) for its Type II diabetes medication Victoza.
Justice Department intervenes in complaint against Los Angeles, alleging fraudulent use of HUD funds
WASHINGTON (Legal Newsline) — The U.S. Department of Justice announced Aug. 1 that it has filed a complaint to intervene against the city of Los Angeles and the CRA/LA (formerly the Community Redevelopment Agency of the city of Los Angeles) alleging the fraudulent securing of millions of dollars in housing grants from the U.S. Department of Housing and Urban Development (HUD).
WASHINGTON (Legal Newsline) — The U.S. Department of Justice announced July 27 that the U.S. District Court for the Eastern District of Tennessee entered a consent decree of permanent injunction against Crown Laboratories Inc. and Chief Executive Officer Jeffrey Bedard to stop the alleged distribution of unapproved and misbranded drugs.
WASHINGTON (Legal Newsline) — The U.S. Department of Justice announced July 26 it has filed a lawsuit against Louisiana-based companies Technical Marine Maintenance Texas LLC, which provides contract shipyard labor, and Gulf Coast Workforce LLC, a related company, for allegedly violating the Immigration and Nationality Act (INA).
WASHINGTON (Legal Newsline) — The U.S. Department of Justice announced July 17 that Ohio-based Foundations Health Solutions Inc. (FHS), Olympia Therapy Inc. (Olympia), and Tridia Hospice Care Inc. (Tridia), and their executives, Brian Colleran (Colleran) and Daniel Parker (Parker), will pay roughly $19.5 million to resolve allegations of false claims to Medicare.